Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
Patient-derived xenograft models (PDX) have been extensively used to study the molecular and clinical features of cancers. Here the authors present a cohort of 536 PDX models from 25 cancers, as well as their genomic and evolutionary profiles and their suitability for clinical trials.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6286532f9bc487a87943a142621d7a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e6286532f9bc487a87943a142621d7a3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e6286532f9bc487a87943a142621d7a32021-12-02T16:35:07ZComprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment10.1038/s41467-021-25177-32041-1723https://doaj.org/article/e6286532f9bc487a87943a142621d7a32021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25177-3https://doaj.org/toc/2041-1723Patient-derived xenograft models (PDX) have been extensively used to study the molecular and clinical features of cancers. Here the authors present a cohort of 536 PDX models from 25 cancers, as well as their genomic and evolutionary profiles and their suitability for clinical trials.Hua SunSong CaoR. Jay MashlChia-Kuei MoSimone ZaccariaMichael C. WendlSherri R. DaviesMatthew H. BaileyTina M. PrimeauJeremy HoogJacqueline L. MuddDennis A. DeanRajesh PatidarLi ChenMatthew A. WyczalkowskiReyka G. JayasingheFernanda Martins RodriguesNadezhda V. TerekhanovaYize LiKian-Huat LimAndrea Wang-GillamBrian A. Van TineCynthia X. MaRebecca AftKatherine C. FuhJulie K. SchwarzJose P. ZevallosSidharth V. PuramJohn F. DipersioThe NCI PDXNet ConsortiumBrandi Davis-DusenberyMatthew J. EllisMichael T. LewisMichael A. DaviesMeenhard HerlynBingliang FangJack A. RothAlana L. WelmBryan E. WelmFunda Meric-BernstamFeng ChenRyan C. FieldsShunqiang LiRamaswamy GovindanJames H. DoroshowJeffrey A. MoscowYvonne A. EvrardJeffrey H. ChuangBenjamin J. RaphaelLi DingNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-20 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Hua Sun Song Cao R. Jay Mashl Chia-Kuei Mo Simone Zaccaria Michael C. Wendl Sherri R. Davies Matthew H. Bailey Tina M. Primeau Jeremy Hoog Jacqueline L. Mudd Dennis A. Dean Rajesh Patidar Li Chen Matthew A. Wyczalkowski Reyka G. Jayasinghe Fernanda Martins Rodrigues Nadezhda V. Terekhanova Yize Li Kian-Huat Lim Andrea Wang-Gillam Brian A. Van Tine Cynthia X. Ma Rebecca Aft Katherine C. Fuh Julie K. Schwarz Jose P. Zevallos Sidharth V. Puram John F. Dipersio The NCI PDXNet Consortium Brandi Davis-Dusenbery Matthew J. Ellis Michael T. Lewis Michael A. Davies Meenhard Herlyn Bingliang Fang Jack A. Roth Alana L. Welm Bryan E. Welm Funda Meric-Bernstam Feng Chen Ryan C. Fields Shunqiang Li Ramaswamy Govindan James H. Doroshow Jeffrey A. Moscow Yvonne A. Evrard Jeffrey H. Chuang Benjamin J. Raphael Li Ding Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment |
description |
Patient-derived xenograft models (PDX) have been extensively used to study the molecular and clinical features of cancers. Here the authors present a cohort of 536 PDX models from 25 cancers, as well as their genomic and evolutionary profiles and their suitability for clinical trials. |
format |
article |
author |
Hua Sun Song Cao R. Jay Mashl Chia-Kuei Mo Simone Zaccaria Michael C. Wendl Sherri R. Davies Matthew H. Bailey Tina M. Primeau Jeremy Hoog Jacqueline L. Mudd Dennis A. Dean Rajesh Patidar Li Chen Matthew A. Wyczalkowski Reyka G. Jayasinghe Fernanda Martins Rodrigues Nadezhda V. Terekhanova Yize Li Kian-Huat Lim Andrea Wang-Gillam Brian A. Van Tine Cynthia X. Ma Rebecca Aft Katherine C. Fuh Julie K. Schwarz Jose P. Zevallos Sidharth V. Puram John F. Dipersio The NCI PDXNet Consortium Brandi Davis-Dusenbery Matthew J. Ellis Michael T. Lewis Michael A. Davies Meenhard Herlyn Bingliang Fang Jack A. Roth Alana L. Welm Bryan E. Welm Funda Meric-Bernstam Feng Chen Ryan C. Fields Shunqiang Li Ramaswamy Govindan James H. Doroshow Jeffrey A. Moscow Yvonne A. Evrard Jeffrey H. Chuang Benjamin J. Raphael Li Ding |
author_facet |
Hua Sun Song Cao R. Jay Mashl Chia-Kuei Mo Simone Zaccaria Michael C. Wendl Sherri R. Davies Matthew H. Bailey Tina M. Primeau Jeremy Hoog Jacqueline L. Mudd Dennis A. Dean Rajesh Patidar Li Chen Matthew A. Wyczalkowski Reyka G. Jayasinghe Fernanda Martins Rodrigues Nadezhda V. Terekhanova Yize Li Kian-Huat Lim Andrea Wang-Gillam Brian A. Van Tine Cynthia X. Ma Rebecca Aft Katherine C. Fuh Julie K. Schwarz Jose P. Zevallos Sidharth V. Puram John F. Dipersio The NCI PDXNet Consortium Brandi Davis-Dusenbery Matthew J. Ellis Michael T. Lewis Michael A. Davies Meenhard Herlyn Bingliang Fang Jack A. Roth Alana L. Welm Bryan E. Welm Funda Meric-Bernstam Feng Chen Ryan C. Fields Shunqiang Li Ramaswamy Govindan James H. Doroshow Jeffrey A. Moscow Yvonne A. Evrard Jeffrey H. Chuang Benjamin J. Raphael Li Ding |
author_sort |
Hua Sun |
title |
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment |
title_short |
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment |
title_full |
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment |
title_fullStr |
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment |
title_full_unstemmed |
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment |
title_sort |
comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/e6286532f9bc487a87943a142621d7a3 |
work_keys_str_mv |
AT huasun comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT songcao comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT rjaymashl comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT chiakueimo comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT simonezaccaria comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT michaelcwendl comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT sherrirdavies comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT matthewhbailey comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT tinamprimeau comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT jeremyhoog comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT jacquelinelmudd comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT dennisadean comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT rajeshpatidar comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT lichen comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT matthewawyczalkowski comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT reykagjayasinghe comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT fernandamartinsrodrigues comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT nadezhdavterekhanova comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT yizeli comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT kianhuatlim comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT andreawanggillam comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT brianavantine comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT cynthiaxma comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT rebeccaaft comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT katherinecfuh comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT juliekschwarz comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT josepzevallos comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT sidharthvpuram comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT johnfdipersio comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT thencipdxnetconsortium comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT brandidavisdusenbery comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT matthewjellis comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT michaeltlewis comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT michaeladavies comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT meenhardherlyn comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT bingliangfang comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT jackaroth comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT alanalwelm comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT bryanewelm comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT fundamericbernstam comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT fengchen comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT ryancfields comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT shunqiangli comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT ramaswamygovindan comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT jameshdoroshow comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT jeffreyamoscow comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT yvonneaevrard comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT jeffreyhchuang comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT benjaminjraphael comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment AT liding comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment |
_version_ |
1718383785131638784 |